{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05454891",
            "orgStudyIdInfo": {
                "id": "58992"
            },
            "secondaryIdInfos": [
                {
                    "id": "5K23DK121942-02",
                    "type": "NIH",
                    "link": "https://reporter.nih.gov/quickSearch/5K23DK121942-02"
                }
            ],
            "organization": {
                "fullName": "University of California, San Francisco",
                "class": "OTHER"
            },
            "briefTitle": "Extended Bolus for Meals in a Closed-loop System",
            "officialTitle": "Postprandial Glucose Control Using an Extended Bolus for High-fat High Protein Meals in a Closed-loop System in Patients With Type 1 Diabetes",
            "therapeuticArea": [
                "Endocrinology"
            ],
            "study": "extended-bolus-for-meals-in-a-closed-loop-system"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-06",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-07-15",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-09-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-11-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-06-24",
            "studyFirstSubmitQcDate": "2022-07-08",
            "studyFirstPostDateStruct": {
                "date": "2022-07-12",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-06-28",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-01",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "University of California, San Francisco",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
                    "class": "NIH"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "This study aims to evaluate whether the use of an extended bolus will improve glucose control with high-fat high protein meals using a closed-loop system. The new knowledge gained from this study may provide a method to allow for the proper administration of insulin over an extended period to mitigate the risk of prolonged hyperglycemia or early hypoglycemia."
        },
        "conditionsModule": {
            "conditions": [
                "Type 1 Diabetes"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE4"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "CROSSOVER",
                "interventionModelDescription": "Participants will be randomly assigned (1:1) in blocks of two to the order in which they receive the two premeal insulin boluses: extended followed by standard bolus or a standard followed by extended bolus.",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 30,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "High Fat High Protein (HFHP) Meal- extended then standard insulin bolus arm",
                    "type": "EXPERIMENTAL",
                    "description": "Subjects will receive extended meal bolus for breakfast on the first day and standard meal bolus on the second day of the study.",
                    "interventionNames": [
                        "Drug: Extended bolus of insulin then standard bolus of insulin"
                    ]
                },
                {
                    "label": "High Fat High Protein (HFHP) Meal- standard then extended insulin bolus arm",
                    "type": "EXPERIMENTAL",
                    "description": "Subjects will receive standard meal bolus for breakfast on the first day and extended meal bolus on the second day.",
                    "interventionNames": [
                        "Drug: Standard bolus of insulin then extended bolus of insulin"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Extended bolus of insulin then standard bolus of insulin",
                    "description": "For a standardized HFHP breakfast, participants will receive an extended meal bolus of insulin on the first morning and a standard meal bolus of insulin on the second morning of the study.",
                    "armGroupLabels": [
                        "High Fat High Protein (HFHP) Meal- extended then standard insulin bolus arm"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Standard bolus of insulin then extended bolus of insulin",
                    "description": "For a standardized HFHP breakfast, participants will receive a standard bolus of insulin on the first morning and an extended bolus of insulin on the second morning of the study.",
                    "armGroupLabels": [
                        "High Fat High Protein (HFHP) Meal- standard then extended insulin bolus arm"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Glucose Area Under Curve [AUC]",
                    "description": "Area under the curve between glucose trace and starting glucose (mg/dL\\* hour)",
                    "timeFrame": "Baseline and 5 hours post-bolus"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Percentage of time between 70-180 mg/dL",
                    "description": "Percentage of time spent between 70-180 mg/dl based on Continuous Glucose Monitor (CGM) values",
                    "timeFrame": "Baseline and 5 hours post-bolus"
                },
                {
                    "measure": "Percentage of time in hypoglycemic range (defined as < 70 mg/dL)",
                    "description": "Percentage of time spent with blood sugar less than 70 mg/dL based on Continuous Glucose Monitor (CGM) values",
                    "timeFrame": "Baseline and 5 hours post-bolus"
                },
                {
                    "measure": "Average glucose",
                    "description": "Average glucose value based on Continuous Glucose Monitor (CGM) values",
                    "timeFrame": "Baseline and 5 hours post-bolus"
                },
                {
                    "measure": "Percentage of time in hyperglycemic range (defined as \u2265180 mg/dL);",
                    "description": "Percentage of time spent with blood sugar higher than 180 mg/dL based on Continuous Glucose Monitor (CGM) values",
                    "timeFrame": "Baseline and 5 hours post-bolus"
                },
                {
                    "measure": "Insulin dosage",
                    "description": "Total insulin received during 5 hrs ( manual bolus as well as automated)",
                    "timeFrame": "Baseline and 5 hours post-bolus"
                },
                {
                    "measure": "Time to target",
                    "description": "Time spent till blood glucose returns to range",
                    "timeFrame": "Baseline and 5 hours post-bolus"
                },
                {
                    "measure": "Time to baseline",
                    "description": "Time spent till blood glucose returns to baseline",
                    "timeFrame": "Baseline and 5 hours post-bolus"
                },
                {
                    "measure": "Time to peak glucose",
                    "description": "Time spent till blood glucose reaches the maximum value after meal",
                    "timeFrame": "Baseline and 5 hours post-bolus"
                },
                {
                    "measure": "Change in glucose",
                    "description": "The difference between baseline to max glucose value",
                    "timeFrame": "Baseline and 5 hours post-bolus"
                },
                {
                    "measure": "Peak glucose concentration",
                    "description": "Max blood glucose",
                    "timeFrame": "Baseline and 5 hours post-bolus"
                },
                {
                    "measure": "Percentage of time between 70-140 mg/dL",
                    "description": "Percent of glucose readings from CGM system between 70-140 mg/dL per unit of time",
                    "timeFrame": "Baseline and 5 hours post-bolus"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria\n\n* Age between 13 and 19 years old, A1C \\> 6% at screening\n* Diagnosed with type 1 diabetes for at least one year\n* Total daily dose (TDD) of insulin \u2265 0.3 units/kg/day\n* Currently using the Control IQ closed-loop system\n* Willing to abide by meal recommendations and study procedures\n* Willing and able to sign the Informed Consent Form (ICF) and/or has a parent or guardian willing and able to sign the ICF\n* Use an Android or Apple smartphone\n* Willingness not to start any new non-insulin glucose-lowering agent during the course of the trial\n* Participant and parent(s)/guardian(s) willingness to participate in all training sessions as directed by study staff\n* Parent/guardian proficient in reading and writing English\n* Live in the United States, with no plans to move outside the United States during the study period\n\nExclusion Criteria\n\n* A1C \\>10%\n* One or more episodes of severe hypoglycemia or DKA requiring ER visit or hospitalization within the past three months\n* Used non-insulin anti-diabetic medication within the last 30 days other than metformin\n* Known history of gastroparesis, seizure disorder, adrenal insufficiency, or ongoing renal or hepatic disease\n* Pregnancy or lactation\n* Untreated or unstable hypothyroidism\n* Currently undergoing cancer treatment or systemic treatment with steroids\n* Untreated or inadequately treated mental illness\n* Current alcohol abuse\n* Current illness that would interfere with participation in the study\n* Delayed gastric emptying or any concurrent conditions that can be associated with delayed gastric emptying or altered digestion; and the use of any medication that affects gastric emptying\n* Celiac Disease",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "13 Years",
            "maximumAge": "19 Years",
            "stdAges": [
                "CHILD",
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Laya Ekhlaspour, MD",
                    "role": "CONTACT",
                    "phone": "415-514-8531",
                    "email": "laya.ekhlaspour@ucsf.edu"
                },
                {
                    "name": "Rebecca Wesch",
                    "role": "CONTACT",
                    "phone": "(415) 476-5984",
                    "email": "Rebecca.wesch@ucsf.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Laya Ekhlaspour, MD",
                    "affiliation": "University of California, San Francisco",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of California San Francisco",
                    "status": "RECRUITING",
                    "city": "San Francisco",
                    "state": "California",
                    "zip": "94158",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Rebecca Wesch",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.77493,
                        "lon": -122.41942
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000003922",
                    "term": "Diabetes Mellitus, Type 1"
                }
            ],
            "ancestors": [
                {
                    "id": "D000003920",
                    "term": "Diabetes Mellitus"
                },
                {
                    "id": "D000044882",
                    "term": "Glucose Metabolism Disorders"
                },
                {
                    "id": "D000008659",
                    "term": "Metabolic Diseases"
                },
                {
                    "id": "D000004700",
                    "term": "Endocrine System Diseases"
                },
                {
                    "id": "D000001327",
                    "term": "Autoimmune Diseases"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M7117",
                    "name": "Diabetes Mellitus, Type 1",
                    "asFound": "Type 1 Diabetes",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7115",
                    "name": "Diabetes Mellitus",
                    "relevance": "LOW"
                },
                {
                    "id": "M11639",
                    "name": "Metabolic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M25403",
                    "name": "Glucose Metabolism Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M7862",
                    "name": "Endocrine System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M4629",
                    "name": "Autoimmune Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "BC19",
                    "name": "Gland and Hormone Related Diseases"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000007328",
                    "term": "Insulin"
                },
                {
                    "id": "C000557859",
                    "term": "Insulin, Globin Zinc"
                }
            ],
            "ancestors": [
                {
                    "id": "D000007004",
                    "term": "Hypoglycemic Agents"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M10365",
                    "name": "Insulin",
                    "asFound": "Day 1",
                    "relevance": "HIGH"
                },
                {
                    "id": "M173166",
                    "name": "Insulin, Globin Zinc",
                    "asFound": "Day 1",
                    "relevance": "HIGH"
                },
                {
                    "id": "M17768",
                    "name": "Zinc",
                    "relevance": "LOW"
                },
                {
                    "id": "M10054",
                    "name": "Hypoglycemic Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Hypo",
                    "name": "Hypoglycemic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Micro",
                    "name": "Micronutrients"
                }
            ]
        }
    },
    "hasResults": false
}